Sunday, January 11, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Insperity Announces ExDividend Date and Quarterly Payout for Shareholders

Elaine Mendonca by Elaine Mendonca
March 1, 2024
in Breaking News
0
Finance_ Charts for stock trading
0
SHARES
7
VIEWS
Share on FacebookShare on Twitter

Insperity, a publicly traded company listed on the New York Stock Exchange under the symbol NSP, will be going ex-dividend on March 1, 2024. Shareholders who hold NSP stock by the end of trading on February 29, 2024, will qualify to receive a quarterly dividend of 57 cents per share. The dividend distribution is slated for March 21, 2024, providing investors with the flexibility to either reinvest the funds back into the company or use the payment for other financial purposes.

NSP Stock Analysis: Potential Buying Opportunity as Price Momentum Increases on March 1, 2024

On March 1, 2024, NSP stock had a mixed performance as it traded near the bottom of its 52-week range and below its 200-day simple moving average. Despite this, the stock saw a slight increase in price momentum, with shares rising by $0.63, or 0.62%, since the market last closed. NSP opened at $101.42 on March 1, which was $0.37 lower than its previous close. This initial decrease in price may have been a cause for concern for some investors, but the subsequent increase in price throughout the trading day could indicate a potential turnaround for the stock. NSP’s current trading position near the bottom of its 52-week range and below its 200-day simple moving average may suggest that the stock is undervalued. This could present a buying opportunity for investors looking to add NSP to their portfolio at a potentially discounted price. Overall, NSP’s performance on March 1, 2024, showed a mix of bearish and bullish signals. While the stock opened lower than its previous close, the subsequent increase in price momentum could indicate a positive trend for NSP in the near future. Investors should continue to monitor NSP’s performance and consider the potential buying opportunity presented by its current trading position.

NSP Stock Performance Analysis: Revenue Up, Net Income Down – March 1, 2024

On March 1, 2024, NSP stock performance was relatively stable compared to the previous year and quarter. The company reported a total revenue of $6.49 billion for the past year, showing a 9.21% increase from the previous year. However, the total revenue held flat at $1.58 billion in the last quarter.

Net income for NSP was reported at $171.38 million for the past year, which is a 4.44% decrease from the previous year. In the last quarter, the net income decreased significantly by 55.88% to $19.56 million.

Earnings per share (EPS) for NSP were $4.47 for the past year, showing a 3.76% decrease from the previous year. The EPS held flat at $0.52 in the last quarter.

Overall, NSP’s stock performance on March 1, 2024, reflected a mixed bag of results. While the total revenue showed a modest increase from the previous year, the net income and EPS saw decreases, especially in the last quarter. Investors may want to closely monitor NSP’s financial performance in the coming quarters to assess the company’s growth prospects and stock potential.

Tags: NSP
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Fresh Del Monte Produce to Pay Quarterly Dividend on March 29 2024

Pfizer Receives Overweight Rating and 45 Price Target from Cantor Fitzgerald Analyst

Finance_ Chart up

Analyst Maintains Neutral Rating on CNX Resources with Increased Price Target

Recommended

Transportation Stock Bull Market

JR Kyushu Implements AIPowered AMD Kria K26 SOM for Enhanced Track Inspection Efficiency and Safety

2 years ago
TMUS stock news

Wedbush Analyst Maintains Outperform Rating and Raises Price Target for Global Payments

2 years ago
JD.com Stock

JD.com Shares Surge on Robust Performance and Strategic Moves

3 months ago
Mobile-handsets

Palantir Technologies Reveals Revenue Projections for Q1 2024

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Procter & Gamble Shares Approach a Critical Juncture

Vital Farms Shares Face Headwinds Amid Forecast Revisions and Insider Activity

Palantir Shares: A Wall Street Divide and a Bold New Price Target

Nvidia Accelerates AI Dominance with Early Chip Launch and Strategic Expansions

Netflix Shares Under Pressure Amid High-Stakes Acquisition Battle

Marvell Technology Shares Face Conflicting Market Cues

Trending

Viking Therapeutics Stock
Analysis

Viking Therapeutics: A Tale of Clinical Progress and Insider Selling

by Felix Baarz
January 11, 2026
0

The shares of Viking Therapeutics, a biotechnology firm, are presenting investors with a conflicting narrative this week....

Astera Labs Stock

Astera Labs Shares Face Selling Pressure Amid Strong Fundamentals

January 11, 2026
Realty Income Stock

Institutional Investors Increase Stakes in Realty Income Amid Strategic Refinancing

January 11, 2026
Procter & Gamble Stock

Procter & Gamble Shares Approach a Critical Juncture

January 11, 2026
Vital Farms Stock

Vital Farms Shares Face Headwinds Amid Forecast Revisions and Insider Activity

January 11, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Viking Therapeutics: A Tale of Clinical Progress and Insider Selling
  • Astera Labs Shares Face Selling Pressure Amid Strong Fundamentals
  • Institutional Investors Increase Stakes in Realty Income Amid Strategic Refinancing

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com